This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mathews, W. R. Articles by Ludens, J. H. Search for Related Content PubMed PubMed Citation Articles by Mathews, W. R. Articles by Ludens, J. H.

Hypertension, Vol 17, 930-935, Copyright © 1991 by American Heart Association

ARTICLES

Mass spectral characterization of an endogenous digitalislike factor from human plasma

WR Mathews, DW DuCharme, JM Hamlyn, DW Harris, F Mandel, MA Clark and JH Ludens
Upjohn Laboratories, Upjohn Company, Kalamazoo, Mich. 49001.

A sodium pump inhibitor has been isolated from human plasma and extensively purified. This material, endogenous digitalislike factor, was examined by a variety of mass spectrometric techniques. A low- resolution fast atom bombardment mass spectrometric analysis of a sample of purified endogenous digitalislike factor revealed a single unique molecular ion in the mass range 100-2,500. The accurate mass was determined to be 585.295 Da in a second high-resolution fast atom bombardment mass spectrometric experiment. Based on this accurate mass, the elemental composition of endogenous digitalislike factor was determined and found to be identical to the elemental composition of the known cardenolide ouabain. Direct comparison of ouabain and endogenous digitalislike factor by linked scan tandem mass spectrometry, derivatization with acetic anhydride coupled with fast atom bombardment mass spectrometry, and analytical high-performance liquid chromatography failed to reveal any differences. We conclude that the endogenous digitalislike factor isolated from human plasma is ouabain or a closely related isomer.

This article has been cited by other articles:

				M. P. Blaustein, J. Zhang, L. Chen, H. Song, H. Raina, S. P. Kinsey, M. Izuka, T. Iwamoto, M. I. Kotlikoff, J. B. Lingrel, et al. The Pump, the Exchanger, and Endogenous Ouabain: Signaling Mechanisms That Link Salt Retention to Hypertension Hypertension, February 1, 2009; 53(2): 291 - 298. [Full Text] [PDF]

				W. Schoner and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536. [Abstract] [Full Text] [PDF]

				J. C. Thundathil, M. Anzar, and M. M. Buhr Na+/K+ATPase as a Signaling Molecule During Bovine Sperm Capacitation Biol Reprod, September 1, 2006; 75(3): 308 - 317. [Abstract] [Full Text] [PDF]

				M. V. Pitzalis, J. M. Hamlyn, E. Messaggio, M. Iacoviello, C. Forleo, R. Romito, E. de Tommasi, P. Rizzon, G. Bianchi, and P. Manunta Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy Eur J Heart Fail, March 1, 2006; 8(2): 179 - 186. [Abstract] [Full Text] [PDF]

				M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton How does salt retention raise blood pressure? Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523. [Abstract] [Full Text] [PDF]

				P. Manunta, B. P. Hamilton, and J. M. Hamlyn Salt intake and depletion increase circulating levels of endogenous ouabain in normal men Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R553 - R559. [Abstract] [Full Text] [PDF]

				N. Bauer, J. Muller-Ehmsen, U. Kramer, N. Hambarchian, C. Zobel, R. H.G. Schwinger, H. Neu, U. Kirch, E.-G. Grunbaum, and W. Schoner Ouabain-Like Compound Changes Rapidly on Physical Exercise in Humans and Dogs: Effects of {beta}-Blockade and Angiotensin-Converting Enzyme Inhibition Hypertension, May 1, 2005; 45(5): 1024 - 1028. [Abstract] [Full Text] [PDF]

				L. V. Rossoni, M. Salaices, M. Miguel, A. M. Briones, L. A. Barker, D. V. Vassallo, and M. J. Alonso Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2110 - H2118. [Abstract] [Full Text] [PDF]

				M. A. El-Masri, B. J. Clark, H. M. Qazzaz, and R. Valdes Jr Human Adrenal Cells in Culture Produce Both Ouabain-like and Dihydroouabain-like Factors Clin. Chem., October 1, 2002; 48(10): 1720 - 1730. [Abstract] [Full Text] [PDF]

				O. Vakkuri, S. S. Arnason, P. Joensuu, J. Jalonen, O. Vuolteenaho, and J. Leppaluoto Radioiodinated Tyrosyl-Ouabain and Measurement of a Circulating Ouabain-like Compound Clin. Chem., January 1, 2001; 47(1): 95 - 101. [Abstract] [Full Text] [PDF]

				M. P. Blaustein and W. J. Lederer Sodium/Calcium Exchange: Its Physiological Implications Physiol Rev, July 1, 1999; 79(3): 763 - 854. [Abstract] [Full Text] [PDF]

				S. J. Veerasingham and F. H. H. Leenen Ouabain- and central sodium-induced hypertension depend on the ventral anteroventral third ventricle region Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H63 - H70. [Abstract] [Full Text] [PDF]

				P. Ferrari, L. Torielli, M. Ferrandi, G. Padoani, L. Duzzi, M. Florio, F. Conti, P. Melloni, L. Vesci, N. Corsico, et al. PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 83 - 94. [Abstract] [Full Text]

				E. M. Graham, O. P. Mishra, and M. Delivoria-Papadopoulos Characterization of a Very-High-Affinity Ouabain Binding Site in Term Fetal Guinea Pig Brain Na+, K+-ATPase Reproductive Sciences, January 1, 1998; 5(1): 2 - 5. [Abstract] [PDF]

				J. R. Shah, J. Laredo, B. P. Hamilton, and J. M. Hamlyn Different Signaling Pathways Mediate Stimulated Secretions Of Endogenous Ouabain and Aldosterone From Bovine Adrenocortical Cells Hypertension, January 1, 1998; 31(1): 463 - 468. [Abstract] [Full Text] [PDF]

				M. Ferrandi, P. Manunta, S. Balzan, J. M. Hamlyn, G. Bianchi, and P. Ferrari Ouabain-like Factor Quantification in Mammalian Tissues and Plasma : Comparison of Two Independent Assays Hypertension, October 1, 1997; 30(4): 886 - 896. [Abstract] [Full Text]

				D. Kantoci, W. J. Wechter, E. D. Murray Jr., S. A. Dewind, D. Borchardt, and S. I. Khan Endogenous Natriuretic Factors 6: The Stereochemistry of a Natriuretic gamma -Tocopherol Metabolite LLU-alpha J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 648 - 656. [Abstract] [Full Text]

				E. D. Murray Jr., W. J. Wechter, D. Kantoci, W.-H. Wang, T. Pham, D. D. Quiggle, K. M. Gibson, D. Leipold, and B. M. Anner Endogenous Natriuretic Factors 7: Biospecificity of a Natriuretic gamma -Tocopherol Metabolite LLU-alpha J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 657 - 662. [Abstract] [Full Text]

				B. S. Huang, J. M. Sancho, R. Garcia-Robles, and F. H. H. Leenen Sympathoexcitatory Effect of Hypothalamic/ Hypophysary Inhibitory Factor in Rats Hypertension, June 1, 1997; 29(6): 1291 - 1295. [Abstract] [Full Text]

				S. Harwood, J. A. Little, G. Gallacher, D. Perrett, R. Edwards, and A. Dawnay Development of enzyme immunoassay for endogenous ouabain-like compound in human plasma Clin. Chem., May 1, 1997; 43(5): 715 - 722. [Abstract] [Full Text] [PDF]

				J. Laredo, J. R. Shah, Z.-r. Lu, B. P. Hamilton, and J. M. Hamlyn Angiotensin II Stimulates Secretion of Endogenous Ouabain From Bovine Adrenocortical Cells via Angiotensin Type 2 Receptors Hypertension, January 1, 1997; 29(1): 401 - 407. [Abstract] [Full Text] [PDF]

				A. Rodriguez-Barbero, C. Martinez-Salgado, A. M. Rodriguez-Lopez, M. Ricote, J. Sancho, and J. M. Lopez-Novoa Effect of Hypothalamic-Hypophysary Inhibitory Factor on Mesangial Cell Activation Hypertension, December 1, 1995; 26(6): 905 - 911. [Abstract] [Full Text]